DISTRIBUTION AND CHARACTERIZATION OF THE [H-3] GRANISETRON-LABELED 5-HT3 RECEPTOR IN THE HUMAN FOREBRAIN

被引:55
作者
BUFTON, KE
STEWARD, LJ
BARBER, PC
BARNES, NM
机构
[1] UNIV BIRMINGHAM,SCH MED,DEPT PHARMACOL,BIRMINGHAM B15 2TT,ENGLAND
[2] UNIV BIRMINGHAM,SCH MED,DEPT PATHOL,BIRMINGHAM B15 2TT,ENGLAND
关键词
5-HT3; RECEPTOR; HUMAN PUTAMEN; H-3] GRANISETRON; VAGUS NERVE;
D O I
10.1016/0028-3908(93)90027-Z
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present study has demonstrated the distribution of [H-3]granisetron-labelled 5-HT3, receptors in the human forebrain with relatively high levels of this receptor in homogenates of hippocampus, caudate nucleus, putamen, nucleus accumbens and amygdala. Lower levels of 5-HT, receptors were found in other brain regions and the cervical vagus nerve. Pharmacological characterization of the labelled 5-HT3, receptor in human putamen homogenates identified a relatively low affinity for d-tubocurarine compared to the 5-HT, receptor in NG108-15 neuroblastoma-glioma cell homogenates. In contrast, the affinities of 19 other 5-HT, receptor ligands were not significantly different for the [H-3]granisetron-labelled receptor in these two preparations. Such findings indicate that the human putamen 5-HT3 recep a unique pharmacology which may have significance given the reported clinical potential of compounds active at this receptor when assessed in animal models of disease.
引用
收藏
页码:1325 / 1331
页数:7
相关论文
共 38 条
  • [1] PHARMACOLOGICAL AND REGIONAL CHARACTERIZATION OF [H-3] LY278584 BINDING-SITES IN HUMAN BRAIN
    ABI-DARGHAM, A
    LARUELLE, M
    WONG, DT
    ROBERTSON, DW
    WEINBERGER, DR
    KLEINMAN, JE
    [J]. JOURNAL OF NEUROCHEMISTRY, 1993, 60 (02) : 730 - 737
  • [2] NEUROPHARMACOLOGY OF EMESIS INDUCED BY ANTI-CANCER THERAPY
    ANDREWS, PLR
    RAPEPORT, WG
    SANGER, GJ
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1988, 9 (09) : 334 - 341
  • [3] IDENTIFICATION AND CHARACTERIZATION OF 5-HYDROXYTRYPTAMINE3 RECOGNITION SITES IN HUMAN-BRAIN TISSUE
    BARNES, JM
    BARNES, NM
    COSTALL, B
    IRONSIDE, JW
    NAYLOR, RJ
    [J]. JOURNAL OF NEUROCHEMISTRY, 1989, 53 (06) : 1787 - 1793
  • [4] BEHAVIORAL PHARMACOLOGY OF 5-HT3-RECEPTOR LIGANDS
    BARNES, JM
    BARNES, NM
    COOPER, SJ
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1992, 16 (01) : 107 - 113
  • [5] CHARACTERIZATION AND AUTORADIOGRAPHIC LOCALIZATION OF 5-HT3 RECEPTOR RECOGNITION SITES IDENTIFIED WITH [3H]-(S)-ZACOPRIDE IN THE FOREBRAIN OF THE RAT
    BARNES, JM
    BARNES, NM
    CHAMPANERIA, S
    COSTALL, B
    NAYLOR, RJ
    [J]. NEUROPHARMACOLOGY, 1990, 29 (11) : 1037 - &
  • [6] IDENTIFICATION AND DISTRIBUTION OF 5-HT3 RECOGNITION SITES WITHIN THE HUMAN BRAIN-STEM
    BARNES, JM
    BARNES, NM
    COSTALL, B
    DEAKIN, JFW
    IRONSIDE, JW
    KILPATRICK, GJ
    NAYLOR, RJ
    RUDD, JA
    SIMPSON, MDC
    SLATER, P
    TYERS, MB
    [J]. NEUROSCIENCE LETTERS, 1990, 111 (1-2) : 80 - 86
  • [7] DIFFERENTIAL BINDING CHARACTERISTICS OF AGONISTS AT 5-HT(3) RECEPTOR RECOGNITION SITES IN NG108-15 NEUROBLASTOMA-GLIOMA CELLS LABELED BY [H-3] (S)-ZACOPRIDE AND [H-3] GRANISETRON
    BARNES, JM
    BARNES, NM
    [J]. BIOCHEMICAL PHARMACOLOGY, 1993, 45 (10) : 2155 - 2158
  • [8] AGONIST INTERACTIONS WITH 5-HT(3) RECEPTOR RECOGNITION SITES IN THE RAT ENTORHINAL CORTEX LABELED BY STRUCTURALLY DIVERSE RADIOLIGANDS
    BARNES, JM
    BARNES, NM
    COSTALL, B
    JAGGER, SM
    NAYLOR, RJ
    ROBERTSON, DW
    ROE, SY
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (02) : 500 - 504
  • [9] BARNES JM, 1991, BR J PHARM S, V102, pP252
  • [10] [H-3] ZACOPRIDE - LIGAND FOR THE IDENTIFICATION OF 5-HT3 RECOGNITION SITES
    BARNES, NM
    COSTALL, B
    NAYLOR, RJ
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (08) : 548 - 551